Cephalosporins: Difference between revisions

 
(10 intermediate revisions by 4 users not shown)
Line 1: Line 1:
==1st Generation==
==1st Generation==
* Skin and soft tissue infections (why is agent of choice before gen sx)
*Skin and soft tissue infections (why is agent of choice before generalized symptoms)
* [[Ceftriaxone_Cross-reactivity|Cross-reactivity of PCN]] allergy <10%
*[[EBQ:Cephalosporin Cross-reactivity|Cross-reactivity of PCN]] allergy <10%


==2nd Generation==
==2nd Generation==
** Intestinal anaerobes (why is agent of choice for colorectal sx)
*Intestinal [[anaerobes]] (why is agent of choice for colorectal sx)
** Largely displaced by 3rd gen agents
*Largely displaced by 3rd gen agents
 
==3rd Generation==
==3rd Generation==
** Drug of choice for serious infections due to:
*Drug of choice for serious infections due to:
*** Klebsiella
**[[Klebsiella]]
*** Enterobacter
**[[Enterobacter]]
*** Proteus
**Proteus
*** Haemophilus
**[[Haemophilus]]
** [[Gonorrhea]]
*[[Gonorrhea]]
** [[Lyme Disease]]
*[[Lyme Disease]]
** [[Meningitis]] (+ vanc and ampicillin)
*[[Meningitis]] (+ [[vanc]] and [[ampicillin]])
** Pseudomonas meningitis (+ AG)
*[[Pseudomonas]] meningitis (+ AG)
 
==4th Generation==
==4th Generation==
** Resistant, nosocomial infections
*Resistant, nosocomial infections


{{Template:Clinically Utilized Antibiotics}}
{{Clinically Utilized Antibiotics}}


==See Also==
==See Also==
Line 25: Line 27:
*[[Cephalosporin Cross-reactivity]]
*[[Cephalosporin Cross-reactivity]]


==Source==
==References==
<references/>
Goodman & Gilman's Pharmacology
Goodman & Gilman's Pharmacology


[[Category:Drugs]]
[[Category:Pharmacology]]
[[Category:ID]]
[[Category:ID]]

Latest revision as of 01:29, 21 February 2021

1st Generation

  • Skin and soft tissue infections (why is agent of choice before generalized symptoms)
  • Cross-reactivity of PCN allergy <10%

2nd Generation

  • Intestinal anaerobes (why is agent of choice for colorectal sx)
  • Largely displaced by 3rd gen agents

3rd Generation

4th Generation

  • Resistant, nosocomial infections

See Also

References

Goodman & Gilman's Pharmacology